Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant neoplasm involving the vermiform appendix
Biomarker and diagnostic research for appendix cancer has been reported in the published literature.
13 clinical trials registered, 3 recruiting. Interventions under study include other interventions, drug therapy, procedural interventions, and medical devices. Pipeline includes 1 PHASE2, 2 PHASE1, 7 NA. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT05780684](https://clinicaltrials.gov/study/NCT05780684) |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:30 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Common questions about appendix cancer
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer |
NA |
Dartmouth-Hitchcock Medical Center |
RECRUITING |
[NCT06715839](https://clinicaltrials.gov/study/NCT06715839) | Target-specific immunoPET Imaging of Digestive System Carcinoma | NA | RenJi Hospital | RECRUITING |
[NCT04907643](https://clinicaltrials.gov/study/NCT04907643) | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | NA | Cedars-Sinai Medical Center | RECRUITING |
205 publications have been identified in PubMed for appendix cancer. Kisho has analyzed 102 by research type. Research spans Review / Meta-Analysis (36%), Clinical Trial Publication (22%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 37 | 36% |
Clinical study results | 22 | 22% |
Disease patterns and progression | 17 | 17% |
Patient case studies | 7 | 7% |
Testing and diagnosis research | 6 | 6% |
Laboratory research | 6 | 6% |
New treatment approaches | 5 | 5% |
Other research | 2 | 2% |
Valtis YK (2026). [PMID: 41052404](https://pubmed.ncbi.nlm.nih.gov/41052404/). *Blood Adv*. [Clinical Trial Publication]
Patel S (2026). [PMID: 41826520](https://pubmed.ncbi.nlm.nih.gov/41826520/). *Ann Surg Oncol*. [Diagnostic / Biomarker]
AbdullGaffar B (2026). [PMID: 41455282](https://pubmed.ncbi.nlm.nih.gov/41455282/). *Ann Diagn Pathol*. [Gene Therapy / Novel Therapeutics]
Pattalachinti VK (2026). [PMID: 42081241](https://pubmed.ncbi.nlm.nih.gov/42081241/). *JAMA Netw Open*. [Clinical Trial Publication]
Miller RM (2026). [PMID: 42057320](https://pubmed.ncbi.nlm.nih.gov/42057320/). *J Surg Oncol*. [Clinical Trial Publication]
Kovalik V (2026). [PMID: 41428018](https://pubmed.ncbi.nlm.nih.gov/41428018/). *Ann Surg Oncol*. [Clinical Trial Publication]
Brar G (2026). [PMID: 41688330](https://pubmed.ncbi.nlm.nih.gov/41688330/). *Clin Colorectal Cancer*. [Gene Therapy / Novel Therapeutics]
Zhou Y (2026). [PMID: 41290081](https://pubmed.ncbi.nlm.nih.gov/41290081/). *Crit Rev Oncol Hematol*. [Review / Meta-Analysis]
Shah MA (2026). [PMID: 41747202](https://pubmed.ncbi.nlm.nih.gov/41747202/). *J Clin Oncol*. [Review / Meta-Analysis]
Kovalik V (2026). [PMID: 41772250](https://pubmed.ncbi.nlm.nih.gov/41772250/). *Ann Surg Oncol*. [Other]